Discontinued — last reported Q4 '25
West Pharmaceutical Services Finance Lease Liabilities (Total) decreased by 5.9% to $4.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 14.3%, from $4.20M to $4.80M. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates higher reliance on lease-based financing for long-term assets, which increases fixed financial obligations and leverage ratios.
This represents the present value of future lease payments for assets where the lease term covers a major part of the as...
Comparable to debt obligations, this metric is analyzed alongside long-term borrowings to assess the total capital structure and financial risk profile of peer energy companies.
finance_lease_liabilities_total| Q4 '21 | Q4 '22 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $3.30M | $3.10M | $3.00M | $4.20M | $4.90M | $5.40M | $5.10M | $4.80M |
| QoQ Change | — | — | — | -6.1% | -3.2% | +40.0% | +16.7% | +10.2% | -5.6% | -5.9% |
| YoY Change | — | — | — | — | — | — | +48.5% | +74.2% | +70.0% | +14.3% |